Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Tomić Maja"'
Autor:
Stepanović-Petrović Radica, Tomić Maja
Publikováno v:
Arhiv za farmaciju, Vol 72, Iss 5, Pp 444-454 (2022)
Autoimmune diseases accompanied by the development of hypothyroidism (Hashimoto's thyroiditis) and hyperthyroidism (Graves' disease) are one of the most common disorders of the thyroid gland. Hypothyroidism is a clinical syndrome that occurs as a res
Externí odkaz:
https://doaj.org/article/657210a7ea244db98b5a78ccf60a903a
Autor:
Tomić Maja, Pecikoza Uroš
Publikováno v:
Arhiv za farmaciju, Vol 72, Iss 3, Pp 300-319 (2022)
In the pediatric population, acute respiratory tract infections (RTIs) are the most common reason for seeking professional help from a physician or a pharmacist. Alleviation of symptoms is the only therapeutic measure in viral RTIs and is an adjunct
Externí odkaz:
https://doaj.org/article/09303db71a5b4b6c835715232f5d99d7
Autor:
Tomić Maja
Publikováno v:
Arhiv za farmaciju, Vol 70, Iss 5, Pp 284-296 (2020)
Venous thromboembolism (VTE; includes deep venous thrombosis, DVT, and pulmonary embolism, PE) represents the third most common acute cardiovascular syndrome. Contemporary VTE management comprises primary prevention in high-risk patients, treatment o
Externí odkaz:
https://doaj.org/article/9d8a13038e1c43c8854e74fbbc3595da
Autor:
Micov Ana, Tomić Maja
Publikováno v:
Arhiv za farmaciju, Vol 69, Iss 1, Pp 15-27 (2019)
Pain management is a challenge and imperative for all health professionals, including pharmacists. The most of visits to community pharmacies involve acute pain issues, such as tension-type headache (TTH) and dysmenorrhea. Pharmacists are the first-l
Externí odkaz:
https://doaj.org/article/4785d2ae93f94bc987020399c5ccacd9
Publikováno v:
Arhiv za farmaciju, Vol 69, Iss 1, Pp 1021-1031 (2019)
Pain is a symptom of most diseases that can significantly impair the patient's quality of life. In many diseases it is impossible to eliminate the cause of pain therefore the real goal of treatment is the removal of pain as a symptom, by application
Externí odkaz:
https://doaj.org/article/128f3147530942ddbffe4357c796ad70
Autor:
Stepanović-Petrović Radica, Tomić Maja
Publikováno v:
Arhiv za farmaciju, Vol 69, Iss 1, Pp 1009-1020 (2019)
Morphine, as a paradigm of opioids, is 'gold standard' in treating severe pain, to which all other drugs are compared. However, abuse and respiratory depression potentials have resulted in 'opiophobia' among health professionals, and underutilization
Externí odkaz:
https://doaj.org/article/f31b94269cac48c98e3d55cd4785a394
Publikováno v:
Arhiv za farmaciju, Vol 68, Iss 6, Pp 1021-1031 (2018)
Pain is a symptom of most diseases that can significantly impair the patient's quality of life. In many diseases it is impossible to eliminate the cause of pain therefore the real goal of treatment is the removal of pain as a symptom, by application
Externí odkaz:
https://doaj.org/article/22e59b837a6047438435460b693e16d2
Autor:
Stepanović-Petrović Radica, Tomić Maja
Publikováno v:
Arhiv za farmaciju, Vol 68, Iss 6, Pp 1009-1020 (2018)
Morphine, as a paradigm of opioids, is 'gold standard' in treating severe pain, to which all other drugs are compared. However, abuse and respiratory depression potentials have resulted in 'opiophobia' among health professionals, and underutilization
Externí odkaz:
https://doaj.org/article/db348d0c9378487e8c7f064ff699395e
Autor:
Stepanović-Petrović Radica, Tomić Maja
Publikováno v:
Arhiv za farmaciju, Vol 66, Iss 6, Pp 257-266 (2016)
Goal of osteoarthritis (OA) treatment is to relieve the pain and to reduce the loss of patient's physical functionality. Therapy consists of: nonpharmacological measures, pharmacotherapy and surgery. Although nonpharmacological approach represents a
Externí odkaz:
https://doaj.org/article/b9efef18ffde4862b94886ae1dd4c7da
Autor:
Račić, Anđelka, Jurišić Dukovski, Bisera, Lovrić, Jasmina, Dobričić, Vladimir, Vučen, Sonja, Micov, Ana, Stepanović-Petrović, Radica, Tomić, Maja, Pecikoza, Uroš, Bajac, Jelena, Krajišnik, Danina
Publikováno v:
In International Journal of Pharmaceutics 25 April 2024 655